By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trevena, Inc. 

Berwyn  Pennsylvania    U.S.A.
Phone: n/a Fax: n/a



Drug Discovery

Company News
Trevena, Inc. (TRVN) CEO To Present At The Cowen and Company 35th Annual Health Care Conference 2/24/2015 10:49:03 AM
Trevena, Inc. (TRVN) Announces Positive Results From Phase 1 Multiple Ascending Dose Study Of TRV734 For Moderate To Severe Acute And Chronic Pain 2/9/2015 9:51:34 AM
Trevena, Inc. (TRVN) CEO To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 9:12:28 AM
Trevena, Inc. (TRVN) Release: TRV027 Phase 2b BLAST-AHF Trial Design Published In Journal Of The American College Of Cardiology: Heart Failure 2/3/2015 11:15:00 AM
Trevena, Inc. (TRVN) Initiates Second Phase 2b Study Of TRV130 For Acute Postoperative Pain 1/7/2015 10:53:05 AM
Trevena, Inc. (TRVN) Appoints Anne M. Phillips To The Board Of Directors 12/17/2014 10:20:06 AM
Trevena, Inc. (TRVN) Announces Closing Of Public Offering And Partial Exercise Of Underwriters’ Option To Purchase Additional Shares 12/11/2014 7:43:37 AM
Trevena, Inc. (TRVN) Announces Pricing Of Public Offering 12/5/2014 3:20:20 PM
Trevena, Inc. (TRVN) Planning $40M Stock Offering 12/3/2014 7:44:26 AM
Trevena, Inc. (TRVN) Announces Commencement Of Public Offering 12/1/2014 11:58:26 AM